Cambridge-based cell therapy firm Vericel Corp. has forged a $142 million deal to license a gel used to help heal burns that made just over $3 million in sales last year at an Israeli company. Vericel (Nasdaq: VCEL) will pay $17.5 million upfront and up to $125 million in milestones to license and sell the burn repair product NexoBrid […]

CAR T-cells are becoming somewhat of a household name, but a new phase I trial is, for the first time, using CAR ‘NKT’ cells, featuring genetic modification of a different immune cell, natural killer cells. Natural killer T-cells have long been known to be important in mediating the immune system’s response to cancer, targeting both tumor cells […]

Despite the number and proportion of women obtaining STEM degrees in the last few decades increasing considerably, representation in leadership positions in their respective fields has been fairly stagnant. According to the National Institutes of Health, “Women comprise half of the employees in the pharmaceutical and medical industries, but available data suggest they represent about 17% […]